부산대학교 도서관

Mittmann G; Division of Digital Prevention, Diagnostics and Therapy Guidance, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Medical Faculty, Heidelberg University, Heidelberg, Germany.; Laiouar-Pedari S; Division of Digital Prevention, Diagnostics and Therapy Guidance, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Mehrtens HA; Division of Digital Prevention, Diagnostics and Therapy Guidance, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Haggenmüller S; Division of Digital Prevention, Diagnostics and Therapy Guidance, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Bucher TC; Division of Digital Prevention, Diagnostics and Therapy Guidance, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Chanda T; Division of Digital Prevention, Diagnostics and Therapy Guidance, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Medical Faculty, Heidelberg University, Heidelberg, Germany.; Gaisa NT; Institute of Pathology, RWTH Aachen University, Aachen, Germany.; Institute of Pathology, University Hospital, University of Ulm, Ulm, Germany.; Wagner M; Department of Pathology, University of Saarland, Homburg Saar Campus, Homburg Saar, Germany.; Klamminger GG; Department of Pathology, University of Saarland, Homburg Saar Campus, Homburg Saar, Germany.; Rau TT; Heinrich-Heine-University and University Hospital Düsseldorf, Düsseldorf, Germany.; Neppl C; Heinrich-Heine-University and University Hospital Düsseldorf, Düsseldorf, Germany.; Compérat EM; Department of Pathology, Medical University of Vienna, Vienna, Austria.; Gocht A; Institute of Pathology, University Hospital Schleswig-Holstein, Lübeck, Germany.; Haemmerle M; Institute of Pathology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.; Rupp NJ; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.; Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Westhoff J; Institute of Pathology, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.; Krücken I; Institute of Pathology, Klinikum Bremen Mitte, Bremen, Germany.; PathoNext GmbH, Leipzig, Germany.; Seidl M; Heinrich-Heine-University and University Hospital Düsseldorf, Düsseldorf, Germany.; Schürch CM; Department of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.; Cluster of Excellence iFIT (EXC 2180) 'Image-Guided and Functionally Instructed Tumor Therapies', University of Tübingen, Tübingen, Germany.; Bauer M; Institute of Pathology, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.; Solass W; Institute of Tissue Medicine and Pathology, University Bern, Bern, Switzerland.; Tam YC; Institute of Pathology, Georgius Agricola Foundation Ruhr, Ruhr University Bochum, Bochum, Germany.; Weber F; Institute of Pathology, University of Regensburg, Regensburg, Germany.; Grobholz R; Faculty of Medicine, University of Zurich, Zurich, Switzerland.; Institute of Pathology, Cantonal Hospital Aarau, Aarau, Switzerland.; Augustyniak J; Laborteam Pathology, Goldach, Switzerland.; Kalinski T; Institute of Pathology, Brandenburg Medical School Theodor Fontane, University Hospital Brandenburg an der Havel, Brandenburg an der Havel, Germany.; Hörner C; Institute for Pathology, University Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.; Mertz KD; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.; Department of Biomedicine (DBM), Pathology of Infectious and Immunologic Diseases, University of Basel, Basel, Switzerland.; Döring C; Pathology Zwickau, MVZ diagnosticum Stollberg, Zweigpraxis Zwickau, Zwickau, Germany.; Erbersdobler A; Institute of Pathology, University Medicine Rostock, Rostock, Germany.; Deubler G; Institute of Pathology, Kreiskliniken Reutlingen, Reutlingen, Germany.; Bremmer F; Institute of Pathology, University Medical Center Goettingen, Goettingen, Germany.; Sommer U; Institute of Pathology, University Hospital of Dresden, Dresden, Germany.; Brodhun M; Institute of Pathology and Neuropathology, HELIOS Klinikum Erfurt, Erfurt, Germany.; Griffin J; School of Medicine and Population Health, University of Sheffield, Sheffield, UK.; Lenon MSL; Department of Pathology, University of Santo Tomas Hospital, Manila, Philippines.; Department of Pathology and Laboratory Medicine, National Kidney and Transplant Institute, Quezon City, Philippines.; Trpkov K; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Rockyview General Hospital, Calgary, AB, Canada.; Cheng L; Department of Pathology and Laboratory Medicine, Department of Surgery (Urology), Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University, and Brown University Health, Providence, RI, USA.; Chen F; Department of Pathology, NYU Langone Health, New York, NY, USA.; Levi A; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.; Cai G; Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.; Nguyen TQ; Department of Pathology, University Medical Centre Utrecht, Utrecht, The Netherlands.; Amin A; Department of Pathology, Warren Alpert Medical School of Brown University, Providence, RI, USA.; Cimadamore A; Pathological Anatomy, University of Udine, Udine, Friuli-Venezia Giulia, Italy.; Shabaik A; Department of Pathology, UC San Diego School of Medicine, La Jolla, CA, USA.; Manucha V; Department of Pathology, University of Mississippi Medical Center, Jackson, MS, USA.; Ahmad N; University of South Florida, Morsani College of Medicine, Department of Pathology & Cell Biology and James A. Haley Veterans' Hospital, Tampa, FL, USA.; Messias N; Department of Pathology and Immunology, Washington University in St. Louis, St. Louis, MO, USA.; Sanguedolce F; Department of Pathology, University of Foggia, Foggia, Italy.; Taheri D; Isfahan Kidney Diseases Research Center, Department of Pathology, Isfahan University of Medical Sciences, Isfahan, Iran.; Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Baraban E; Department of Pathology, Johns Hopkins University, Baltimore, MD, USA.; Jia L; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Shah RB; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Siadat F; Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Rockyview General Hospital, Calgary, AB, Canada.; Swarbrick N; Department of Anatomical Pathology, PathWest Laboratory Medicine WA, Perth, WA, Australia.; Division of Pathology and Laboratory Medicine, UWA Medical School, Crawley, WA, Australia.; Park K; Department of Pathology, NYU Langone Health, New York, NY, USA.; Hassan O; Department of Pathology, Henry Ford Health System, Detroit, MI, USA.; Sakhaie S; Department of Anatomical Pathology, Frankston Laboratory, Dorevitch Pathology, Frankston, VIC, Australia.; Downes MR; Anatomic Pathology, Precision Diagnostics & Therapeutics Program, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Miyamoto H; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.; Williamson SR; Department of Pathology, Diagnostics Institute, Cleveland Clinic, Cleveland, OH, USA.; Holland-Letz T; Division of Biostatistics, German Cancer Research Center(DKFZ), Heidelberg, Germany.; Wies C; Division of Digital Prevention, Diagnostics and Therapy Guidance, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Medical Faculty, Heidelberg University, Heidelberg, Germany.; Schneider CV; Department of Internal Medicine, University Hospital Aachen, RWTH University of Aachen, Aachen, Germany.; Kather JN; Else Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; Department of Medicine I, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany.; Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany.; Pathology & Data Analytics, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.; Tolkach Y; Institute of Pathology, University Hospital Cologne, Cologne, Germany.; Medical Faculty, University of Cologne, Cologne, Germany.; Brinker TJ; Division of Digital Prevention, Diagnostics and Therapy Guidance, German Cancer Research Center (DKFZ), Heidelberg, Germany. titus.brinker@dkfz.de.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Schöpfer L; Department of Pathology, Medical University of Vienna, Vienna, Austria.; Zisser L; Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria.; Oberndorfer F; Department of Pathology, Medical University of Vienna, Vienna, Austria.; Schiefer AI; Department of Pathology, Medical University of Vienna, Vienna, Austria.; Compérat EM; Department of Pathology, Medical University of Vienna, Vienna, Austria.; Müllauer L; Department of Pathology, Medical University of Vienna, Vienna, Austria.; Oszwald A; Department of Pathology, Medical University of Vienna, Vienna, Austria. andre.oszwald@meduniwien.ac.at.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

Youssef R; Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA.; Saeed OA; Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA.; Baraban E; Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.; Salimian M; Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.; Iczkowski KA; Department of Pathology, University of California-Davis, Sacramento, California, USA.; Chung LJ; Department of Pathology, University of California-Davis, Sacramento, California, USA.; Baniak N; Department of Pathology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.; Compérat EM; Department of Pathology, Medical University of Vienna, Vienna, Austria.; Wang Y; Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, USA.; van Leenders GJ; Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Sangoi AR; Department of Pathology, Stanford University, Stanford, California, USA.; Wu DJ; Department of Pathology, Stanford University, Stanford, California, USA.; Osunkoya AO; Department of Pathology, Emory University School of Medicine, Atlanta, Georgia, USA.; Kandukuri S; Department of Pathology, Keck School of Medicine of USC, Los Angeles, California, USA.; Cuber A; Department of Pathology, Keck School of Medicine of USC, Los Angeles, California, USA.; Michalova K; Department of Pathology, Charles University, Faculty of Medicine in Plzeň, Bioptical Laboratory, Ltd., Pilsen, Czech Republic.; Strakova-Peterikova A; Department of Pathology, Charles University, Faculty of Medicine in Plzeň, Bioptical Laboratory, Ltd., Pilsen, Czech Republic.; Martignoni G; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, Italy.; Department of Pathology, Pederzoli Hospital, Verona, Italy.; Caliò A; Department of Diagnostics and Public Health, Section of Pathology, University of Verona, Verona, Italy.; Marcolini L; Department of Pathology, Pederzoli Hospital, Verona, Italy.; Miyamoto H; Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, USA.; Pecoraro A; Department of Urology, Pederzoli Hospital, Verona, Italy.; Tsuzuki T; Department of Pathology, Aichi Medical University Hospital, Nagakute, Aichi, Japan.; Acosta AM; Department of Pathology, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7704136 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2559 (Electronic) Linking ISSN: 03090167 NLM ISO Abbreviation: Histopathology Subsets: MEDLINE

Rodríguez-Sánchez L; Urology Department, Institut Mutualiste Montsouris, Paris, France.; Reiter R; Department of Urology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.; Rodríguez A; Department of Urology, Atrium Health Wake Forest Baptist Medical Center, Winston Salem, North Carolina, USA.; Emberton M; Division of Surgery and Interventional Science, University College London, London, UK.; de Reijke T; Amsterdam UMC, department of Urology, University of Amsterdam, Amsterdam, The Netherlands.; Compérat EM; Department of Pathology, Medical University of Vienna, General Hospital of Vienna, Vienna, Austria.; Bossi A; Genitourinary Oncology, Prostate Brachytherapy Unit, Gustave Roussy, Paris, France.; Sanchez-Salas R; Department of Surgery, Division of Urology, McGill University, Montreal, Quebec, Canada.

Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1464-410X (Electronic) Linking ISSN: 14644096 NLM ISO Abbreviation: BJU Int Subsets: MEDLINE

Contieri R; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Biochemical Science, Humanitas University, Milan, Italy; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy.; Martini A; Department of Urology, University of Cincinnati, Cincinnati, OH, USA.; Beijert IJ; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Hentschel AE; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Bründl J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Compérat EM; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Plass K; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; Rodríguez O; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Subiela Henríquez JD; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Hernández V; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; de la Peña E; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Alemany I; Department of Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Turturica D; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Pisano F; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Čapoun O; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.; Bauerová L; Department of Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.; Pešl M; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.; Maxim Bruins H; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Runneboom W; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Herdegen S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Breyer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Brisuda A; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia.; Calatrava A; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Rubio-Briones J; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Seles M; Department of Urology, Medical University of Graz, Graz, Austria.; Mannweiler S; Department of Pathology, Medical University of Graz, Graz, Austria.; Bosschieter J; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Kusuma VRM; Department of Urology, Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Ashabere D; Department of Urology, Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Huebner N; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Seisen T; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; GRC No. 5 ONCOTYPE-URO, Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France.; Claps F; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Masson-Lecomte A; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Saint-Louis Hospital, AP-HP, Paris Cité University, Paris, France.; Liedberg F; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Skaanes Universitetssjukhus, Malmö, Sweden.; Cohen D; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Royal Free London NHS Foundation Trust, London, UK.; Lunelli L; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Cussenot O; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Sheikh SE; Department of Pathology, Royal Free London NHS Foundation Trust, London, UK.; Volanis D; Department of Urology, Royal Free London NHS Foundation Trust, London, UK.; Côté JF; Department of Pathology, Pitié Salpétrière Hospital, AP-HP and Pierre et Marie Curie Medical School, Sorbonne University, Paris, France.; Rouprêt M; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; GRC No. 5 ONCOTYPE-URO, Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France.; Haitel A; Department of Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Shariat SF; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Mostafid AH; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Zigeuner R; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Medical University of Graz, Graz, Austria.; Dominguez-Escrig JL; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Hacek J; Department of Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia.; Zlotta AR; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Burger M; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Evert M; Department of Pathology, University of Regensburg, Regensburg, Germany.; de Kaa CAH; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Kiemeney LALM; IQ Health and Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Soukup V; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.; Molinaro L; Department of Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Hurle R; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy.; Paciotti M; Department of Biochemical Science, Humanitas University, Milan, Italy; Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Italy.; Moschini M; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Milan, Italy.; Pradere B; Department of Urology UROSUD, La Croix du Sud Hôpital, Quint Fonsegrives, France.; Perdonà S; Uro-Gynecological Department, Istituto Nazionale Tumori di Napoli G. Pascale IRCCS, Naples, Italy.; Gontero P; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Llorente C; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Algaba F; Department of Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Palou J; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; N'Dow J; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; Ribal MJ; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Babjuk M; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Sylvester RJ; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. Electronic address: b.v.rhijn@nki.nl.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

Rai BP; Department of Urology, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.; Parmar K; Department of Urology, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.; Pradere B; Department of Urology, UROSUD, La Croix Du Sud Hospital, Quint Fonsegrives, France.; Capoun O; Department of Urology, General University Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Soukup V; Department of Urology, General University Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Gontero P; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Birtle A; Rosemere Cancer Centre, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.; Compérat EM; Department of Pathology, Medical University of Vienna, Vienna, Austria.; Dominguez-Escrig JL; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Yuan Y; Department of Medicine, London Health Science Centre, Western University, London, Ontario, Canada.; Liedberg F; Department of Urology, Skåne University Hospital, Malmö, Sweden.; Mostafid H; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Rouprêt M; GRC 5, Predictive Onco-Urology, Department of Urology, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University, Paris, France.; Teoh JY; S.H. Ho Urology Centre, Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.; Moschini M; Department of Urology, San Raffaele Hospital and Scientific Institute, Milan, Italy.; Mariappan P; Edinburgh Bladder Cancer Surgery (EBCS), Western General Hospital, The University of Edinburgh, Edinburgh, UK.; van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Shariat SF; Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University Vienna, Vienna, Austria.; Xylinas E; Department of Urology, Bichat-Claude Bernard Hospital, Assistance Publique-Hôpitaux de Paris, Université de Paris Cité, Paris, France.; Masson-Lecomte A; Department of Urology, APHP, Saint Louis Hospital, Université de Paris, Paris, France.; Seisen T; GRC 5, Predictive Onco-Urology, Department of Urology, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne University, Paris, France. Electronic address: thomas.seisen@aphp.fr.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

Beijert IJ; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Hentschel AE; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Bründl J; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Compérat EM; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Plass K; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands.; Rodríguez O; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Subiela Henríquez JD; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Hernández V; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; de la Peña E; Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Alemany I; Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Turturica D; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy.; Pisano F; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy.; Soria F; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy.; Čapoun O; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Bauerová L; Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Pešl M; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Bruins HM; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Urology, Zuyderland Medical Center, Sittard/Heerlen, The Netherlands.; Runneboom W; Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Herdegen S; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Breyer J; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Brisuda A; Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Calatrava A; Pathology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain.; Rubio-Briones J; Urology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain.; Seles M; Urology, Medical University of Graz, Graz, Austria.; Mannweiler S; Pathology, Medical University of Graz, Graz, Austria.; Bosschieter J; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Kusuma VRM; Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Ashabere D; Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Huebner N; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Cotte J; Urology, Pitié Salpétrière Hospital, AP-HP, GRC no 5, ONCOTYPE-URO, Sorbonne University, 75013, Paris, France.; Contieri R; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Claps F; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Masson-Lecomte A; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Liedberg F; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Cohen D; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Royal Free London-NHS Foundation Trust, Royal Free Hospital, London, UK.; Lunelli L; Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Cussenot O; Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; El Sheikh S; Pathology, Royal Free London-NHS Foundation Trust, Royal Free Hospital, London, UK.; Volanis D; Urology, Royal Free London-NHS Foundation Trust, Royal Free Hospital, London, UK.; Côté JF; Pathology, Pierre et Marie Curie Medical School, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France.; Rouprêt M; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Pitié Salpétrière Hospital, AP-HP, GRC no 5, ONCOTYPE-URO, Sorbonne University, 75013, Paris, France.; Haitel A; Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Shariat SF; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Mostafid AH; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Nieuwenhuijzen JA; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Zigeuner R; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Medical University of Graz, Graz, Austria.; Dominguez-Escrig JL; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain.; Hacek J; Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Zlotta AR; Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Burger M; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Evert M; Pathology, University of Regensburg, Regensburg, Germany.; Hulsbergen-van de Kaa CA; Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; van der Heijden AG; Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Kiemeney LALM; Health Evidence and Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Soukup V; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Molinaro L; Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy.; Gontero P; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Turin, Italy.; Llorente C; Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Algaba F; Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Palou J; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; N'Dow J; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands.; Ribal MJ; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands.; van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Babjuk M; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Sylvester RJ; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni Van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. b.v.rhijn@nki.nl.; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany. b.v.rhijn@nki.nl.; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands. b.v.rhijn@nki.nl.; Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. b.v.rhijn@nki.nl.

Publisher: Springer Country of Publication: Netherlands NLM ID: 0262521 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2584 (Electronic) Linking ISSN: 03011623 NLM ISO Abbreviation: Int Urol Nephrol Subsets: MEDLINE

Amin MB; Smith SC; Agaimy A; Argani P; Compérat EM; Delahunt B; Epstein JI; Eble JN; Grignon DJ; Hartmann A; Hes O; Hirsch MS; Jimenez RE; Kunju LP; MARTIGNONI, Guido; McKenney JK; Moch H; Montironi R; Paner GP; Rao P; Srigley JR; Tickoo SK; Reuter VE

American Journal of Surgical Pathology. 38:871-874

van der Weyden L; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.; Bertram CA; Department of Biological Sciences and Pathobiology, University of Veterinary Medicine Vienna, 1210, Vienna, Austria. Electronic address: Christof.Bertram@vetmeduni.ac.at.; Dinhopl N; Department of Biological Sciences and Pathobiology, University of Veterinary Medicine Vienna, 1210, Vienna, Austria.; Triebl M; Vogelweiderstraße 21, 5020, Salzburg, Austria.; Donovan TA; Department of Anatomic Pathology, Schwarzman Animal Medical Center, New York, 10065, USA.; Compérat EM; Department of Pathology, Medical University of Vienna, General Hospital of Vienna, 1090, Vienna, Austria.

Publisher: Elsevier Country of Publication: England NLM ID: 0102444 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3129 (Electronic) Linking ISSN: 00219975 NLM ISO Abbreviation: J Comp Pathol Subsets: MEDLINE

Beijert IJ; Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands. Electronic address: i.j.beijert@amsterdamumc.nl.; Hagberg O; Institution of Translational Medicine, Lund University, Malmö, Sweden.; Gårdmark T; Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden.; Holmberg L; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Häggström C; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Northern Registry Centre, Department of Diagnostics and Intervention, Umeå University, Umeå, Sweden.; Johnston A; Department of Urology, Queen Elizabeth University Hospital, Glasgow, UK.; Trail M; Department of Urology, Ninewells Hospital, Dundee, UK.; Hamid S; Department of Urology, Ninewells Hospital, Dundee, UK.; Dreyer BA; Department of Urology, Victoria Hospital, Kirkcaldy, UK.; Padovani L; Edinburgh Bladder Cancer Surgery, Department of Urology, Western General Hospital, Edinburgh, UK.; Garau R; Edinburgh Bladder Cancer Surgery, Department of Urology, Western General Hospital, Edinburgh, UK.; Hasan R; Edinburgh Bladder Cancer Surgery, Department of Urology, Western General Hospital, Edinburgh, UK; Department of Urology, University Hospital Ayr, Ayr, UK.; Ahmad I; Department of Urology, Queen Elizabeth University Hospital, Glasgow, UK; School of Cancer Sciences, University of Glasgow, Glasgow, UK.; Hendry D; Department of Urology, Queen Elizabeth University Hospital, Glasgow, UK.; Compérat EM; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Burger M; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Rouprêt M; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Pitié Salpétrière Hospital, AP-HP, GRC n°5, ONCOTYPE-URO, Sorbonne University, Paris, France.; Gontero P; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Ribal MJ; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands.; van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Babjuk M; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Sylvester RJ; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Mariappan P; Edinburgh Bladder Cancer Surgery, Department of Urology, Western General Hospital, Edinburgh, UK; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; University of Edinburgh, Edinburgh, UK. Electronic address: Param.Mariappan@nhs.scot.; Liedberg F; Institution of Translational Medicine, Lund University, Malmö, Sweden; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Skåne University Hospital, Malmö, Sweden. Electronic address: fredrik.liedberg@med.lu.se.; van Rhijn BWG; Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. Electronic address: b.v.rhijn@nki.nl.

Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

Lobo J; Department of Pathology, Portuguese Oncology Institute of Porto (IPOP), Porto, Portugal.; Cancer Biology and Epigenetics Group, Research Center of IPO Porto (GEBC CI-IPOP)/RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto)/Porto Comprehensive Cancer Center (P.CCC), Porto, Portugal.; Department of Pathology and Molecular Immunology, ICBAS-School of Medicine and Biomedical Sciences, University of Porto (ICBAS-UP), Porto, Portugal.; Ohashi R; Histopathology Core Facility, Niigata University Faculty of Medicine, Niigata, Japan.; Division of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.; Amin MB; Department of Pathology and Laboratory Medicine, University of Tennessee Health Sciences Center, Memphis, USA.; Department of Urology, University of Southern California, Los Angeles, CA, USA.; Berney DM; Centre for Molecular Oncology, Barts and the London School of Medicine and Dentistry, London, UK.; Compérat EM; Department of Pathology, Hôpital Tenon, Sorbonne University, Paris, France.; Cree IA; International Agency for Research on Cancer (IARC), World Health Organization, Lyon, France.; Gill AJ; Sydney Medical School, The University of Sydney, Sydney, Australia.; Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia.; NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, NSW Health Pathology, St Leonards, New South Wales, Australia.; Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.; Menon S; Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India.; Netto GJ; Department of Pathology, University of Alabama, Birmingham, AL, USA.; Raspollini MR; Histopathology and Molecular Diagnostics, Careggi University Hospital, Florence, Italy.; Rubin MA; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY, USA.; Department for BioMedical Research, University of Bern, Bern, Switzerland.; Englander Institute for Precision Medicine, Weill Cornell Medical College, New York, NY, USA.; Tan PH; Division of Pathology, Singapore General Hospital, Singapore.; Tickoo SK; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Tsuzuki T; Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute, Japan.; Turajlic S; Renal and Skin Units, The Royal Marsden Hospital NHS Foundation Trust, London, UK.; The Francis Crick Institute, London, UK.; Zhou M; Department of Pathology, Tufts Medical Center, Boston, Massachusetts, USA.; Srigley JR; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Moch H; Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland.

Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7704136 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2559 (Electronic) Linking ISSN: 03090167 NLM ISO Abbreviation: Histopathology Subsets: MEDLINE

Kench JG; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, NSW Health Pathology, Camperdown, New South Wales, Australia.; The University of Sydney, Camperdown, New South Wales, Australia.; Amin MB; The University of Tennessee Health Science Center, Memphis, TN, USA.; Berney DM; Department of Cellular Pathology, Bartshealth NHS Trust, Royal London Hospital, London, UK.; Compérat EM; Department of Pathology, University of Vienna, Vienna, Austria.; Cree IA; International Agency for Research on Cancer, Lyon, France.; Gill AJ; The University of Sydney, Camperdown, New South Wales, Australia.; NSW Health Pathology, Department of Anatomical Pathology, Royal North Shore Hospital, Pacific Highway, St Leonards, New South Wales, Australia.; Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.; Menon S; Department of Pathology, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.; Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.; Netto GJ; Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.; Raspollini MR; Histopathology and Molecular Diagnostics, University Hospital Careggi, Florence, Italy.; Rubin MA; Department for BioMedical Research, University of Bern, Bern, Switzerland.; Tan PH; Division of Pathology, Singapore General Hospital, Singapore, Singapore.; Tsuzuki T; Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute, Japan.; Turjalic S; Skin and Renal Units, Royal Marsden NHS Foundation Trust, London, UK.; Cancer Dynamics Laboratory, The Francis Crick Institute, London, UK.; van der Kwast TH; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Zhou M; Pathology and Laboratory Medicine, Tufts Medical Center, Boston, MA, USA.; Srigley JR; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7704136 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2559 (Electronic) Linking ISSN: 03090167 NLM ISO Abbreviation: Histopathology Subsets: MEDLINE

Bor, C. ; Haymann, JP. ; Perie, S. ; Comperat, EM. ; Livrozet, M. ; Cheddani, L. ; Traxer, O. ; Letavernier, E.

In Annales d'Endocrinologie September 2018 79(4):219-219

Eckstein M; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.; Matek C; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.; Wagner P; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.; Erber R; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.; Büttner-Herold M; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany; Department of Nephropathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Wild PJ; Dr. Senckenberg Institute of Pathology (SIP), University Hospital Frankfurt & Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; Taubert H; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Wach S; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Sikic D; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Wullich B; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Geppert CI; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.; Compérat EM; Department of Pathology, Medical University of Vienna, Vienna, Austria.; Lopez-Beltran A; Unit of Anatomical Pathology, Faculty of Medicine, Cordoba University, Cordoba, Spain.; Montironi R; Molecular Medicine and Cell Therapy Foundation, c/o Polytechnic University of the Marche Region, Ancona, Italy.; Cheng L; Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Providence, RI, USA; The Legorreta Cancer Center at Brown University, Providence, RI, USA.; van der Kwast T; Laboratory Medicine Program, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.; Colecchia M; Vita-Salute San Raffaele University, IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy.; van Rhijn BWG; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Amin MB; Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN, USA; Department of Urology, USC Keck School of Medicine, Los Angeles, CA, USA.; Netto GJ; Department of Pathology and Laboratory Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.; Lehmann J; Urologische Gemeinschaftspraxis Prüner Gang, Kiel, Germany; Department of Urology, Städtisches Krankenhaus Kiel, Kiel, Germany.; Stöckle M; Department of Urology and Pediatric Urology, Saarland University, Homburg/Saar, Germany.; Junker K; Department of Urology and Pediatric Urology, Saarland University, Homburg/Saar, Germany.; Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.; Bertz S; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany. Electronic address: simone.bertz@uk-erlangen.de.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

Eckstein M; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.; Matek C; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.; Wagner P; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.; Erber R; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.; Büttner-Herold M; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany; Department of Nephropathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Wild PJ; Dr. Senckenberg Institute of Pathology (SIP), University Hospital Frankfurt & Frankfurt Cancer Institute (FCI), Goethe University Frankfurt, Frankfurt, Germany.; Taubert H; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Wach S; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Sikic D; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Wullich B; Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.; Geppert CI; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.; Compérat EM; Department of Pathology, Medical University of Vienna, Vienna, Austria.; Lopez-Beltran A; Unit of Anatomical Pathology, Faculty of Medicine, Cordoba University, Cordoba, Spain.; Montironi R; Molecular Medicine and Cell Therapy Foundation, c/o Polytechnic University of the Marche Region, Ancona, Italy.; Cheng L; Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Providence, RI, USA; The Legorreta Cancer Center at Brown University, Providence, RI, USA.; van der Kwast T; Laboratory Medicine Program, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.; Colecchia M; Vita-Salute San Raffaele University, IRCCS San Raffaele Hospital and Scientific Institute, Milan, Italy.; van Rhijn BWG; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Amin MB; Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, Memphis, TN, USA; Department of Urology, USC Keck School of Medicine, Los Angeles, CA, USA.; Netto GJ; Department of Pathology and Laboratory Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.; Lehmann J; Urologische Gemeinschaftspraxis Prüner Gang, Kiel, Germany; Department of Urology, Städtisches Krankenhaus Kiel, Kiel, Germany.; Stöckle M; Department of Urology and Pediatric Urology, Saarland University, Homburg/Saar, Germany.; Junker K; Department of Urology and Pediatric Urology, Saarland University, Homburg/Saar, Germany.; Hartmann A; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany.; Bertz S; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany; Comprehensive Cancer Center EMN, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany; Bavarian Center for Cancer Research (BZKF), Erlangen, Germany. Electronic address: simone.bertz@uk-erlangen.de.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: PubMed not MEDLINE; MEDLINE

Rouprêt M; GRC 5 Predictive Onco-Uro, Sorbonne University, AP-HP, Urology, Pitie-Salpetriere Hospital, Paris, France. Electronic address: morgan.roupret@aphp.fr.; Seisen T; GRC 5 Predictive Onco-Uro, Sorbonne University, AP-HP, Urology, Pitie-Salpetriere Hospital, Paris, France.; Birtle AJ; Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK; University of Manchester, Manchester, UK.; Capoun O; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Pathology, General Hospital of Vienna, Medical University of Vienna, Vienna, Austria.; Compérat EM; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Pathology, General Hospital of Vienna, Medical University of Vienna, Vienna, Austria; Department of Pathology, Sorbonne University, AP-HP, Hôpital Tenon, Paris.; Dominguez-Escrig JL; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Gürses Andersson I; Patient advocate, Bladder Cancer Norway, Norway.; Liedberg F; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden.; Mariappan P; Department of Urology, Edinburgh Bladder Cancer Surgery, Western General Hospital, Edinburgh, UK.; Hugh Mostafid A; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Pradere B; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, La Croix Du Sud Hospital, Quint Fonsegrives, France.; van Rhijn BWG; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Shariat SF; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Rai BP; Department of Urology, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.; Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Soukup V; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Pathology, General Hospital of Vienna, Medical University of Vienna, Vienna, Austria.; Wood RG; Patient advocate, Bladder Cancer Norway, Norway.; Xylinas EN; Department of Urology, Bichat-Claude Bernard Hospital, AP-HP, Université de Paris, Paris, France.; Masson-Lecomte A; Department of Urology, Université de Paris, AP-HP, Saint Louis Hospital, Paris, France.; Gontero P; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.

Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

van Rhijn BWG; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. Electronic address: basvanrhijn@hotmail.com.; Hentschel AE; Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Bründl J; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Compérat EM; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Hernández V; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Čapoun O; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Bruins HM; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Cohen D; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Royal Free London - NHS Foundation Trust, Royal Free Hospital, London, UK.; Rouprêt M; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Pitié Salpétrière Hospital, AP-HP, GRC n°5, ONCOTYPE-URO, Sorbonne University, Paris, France.; Shariat SF; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Mostafid AH; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Zigeuner R; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Medical University of Graz, Graz, Austria.; Dominguez-Escrig JL; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Fundación Instituto Valenciano de Oncología (I.V.O.), Valencia, Spain.; Burger M; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Soukup V; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Gontero P; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Palou J; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Babjuk M; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Sylvester RJ; European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

Beijert IJ; Department of Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Cheng L; Department of Pathology and Laboratory Medicine, Brown University Warren Alpert Medical School, Lifespan Academic Medical Center and Legorreta Cancer Center at Brown University, Providence, RI, USA.; Liedberg F; Department of Translational Medicine, Lund University, Malmö, Sweden.; Department of Urology, Skåne University Hospital, Malmö, Sweden.; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Plass K; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands.; Williamson SR; Department of Pathology, Cleveland Clinic, Cleveland, OH, USA.; Gontero P; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Ribal MJ; European Association of Urology, Guidelines Office Board, Arnhem, The Netherlands.; Department of Urology, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain.; Babjuk M; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Kamat AM; Department of Urology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.; Algaba F; Department of Pathology, Fundació Puigvert, Universitat Autónoma de Barcelona, Barcelona, Spain.; Berman DM; Kingston Health Sciences Centre, Queen's University, Kingston, ON, Canada.; Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.; Hartmann A; Institute of Pathology, Friedrich-Alexander-University of Erlangen-Nürnberg, Erlangen, Germany.; Masson-Lecomte A; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Department of Urology, Université de Paris, APHP, Saint Louis Hospital, Paris, France.; Rouprêt M; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Department of Urology, Pitié Salpétrière Hospital, AP-HP, GRC n°5, ONCOTYPE-URO, Sorbonne University, Paris, France.; Lopez-Beltran A; Department of Morphological Sciences, University of Cordoba Medical School, Cordoba, Spain.; Anatomic Pathology, Champalimaud Clinical Center, Lisbon, Portugal.; Samaratunga H; Department of Pathology, Aquesta Uropathology and University of Queensland, Brisbane, Australia.; Shariat SF; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Mostafid AH; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Varma M; Department of Cellular Pathology, University Hospital of Wales, Cardiff, UK.; Shen S; Department of Pathology Genomic Medicine, Houston Methodist Hospital and Weill Cornell Medical College, Houston, TX, USA.; Burger M; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Tsuzuki T; Department of Surgical Pathology, Aichi Medical University Hospital, Nagakute, Japan.; Palou J; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Compérat EM; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Department of Pathology, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Sylvester RJ; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; European Association of Urology, Non-Muscle Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Downes MR; Division of Anatomic Pathology, Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101771568 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-1683 (Electronic) Linking ISSN: 26661683 NLM ISO Abbreviation: Eur Urol Open Sci Subsets: PubMed not MEDLINE

Sylvester RJ; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands. Electronic address: richard.sylvester@skynet.be.; Rodríguez O; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Hernández V; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Turturica D; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Bauerová L; Department of Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Max Bruins H; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Bründl J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Brisuda A; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Rubio-Briones J; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Seles M; Department of Urology, Medical University of Graz, Graz, Austria.; Hentschel AE; Department of Urology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Kusuma VRM; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Huebner N; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Cotte J; Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France.; Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Volanis D; Department of Urology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Cussenot O; Department of Urology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Subiela Henríquez JD; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; de la Peña E; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Pisano F; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Pešl M; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Herdegen S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Zlotta AR; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Hacek J; Department of Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Calatrava A; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Mannweiler S; Department of Pathology, Medical University of Graz, Graz, Austria.; Bosschieter J; Department of Urology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands.; Ashabere D; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Haitel A; Department of Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Côté JF; Department of Pathology, Pitié Salpétrière Hospital, AP-HP, Pierre et Marie Curie Medical School, Sorbonne University, Paris, France.; El Sheikh S; Department of Pathology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Lunelli L; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Algaba F; Department of Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Alemany I; Department of Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Runneboom W; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Breyer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Center, Vrije Universiteit, Amsterdam, The Netherlands.; Llorente C; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Molinaro L; Department of Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Hulsbergen-van de Kaa CA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Evert M; Department of Pathology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Kiemeney LALM; Department of Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.; N'Dow J; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; Plass K; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; Čapoun O; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Soukup V; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czech Republic.; Dominguez-Escrig JL; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Cohen D; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Royal Free London NHS Foundation Trust, Royal Free Hospital, London, UK.; Palou J; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Gontero P; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Burger M; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Zigeuner R; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Medical University of Graz, Graz, Austria.; Mostafid AH; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Shariat SF; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Rouprêt M; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Pitié Salpétrière Hospital, AP-HP, Sorbonne University, Paris, France.; Compérat EM; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Babjuk M; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czech Republic; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; van Rhijn BWG; European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.

Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: PubMed not MEDLINE; MEDLINE

Beijert IJ; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Hentschel AE; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Bründl J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Compérat EM; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Plass K; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; Rodríguez O; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Subiela Henríquez JD; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Hernández V; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; de la Peña E; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Alemany I; Department of Pathology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Turturica D; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Pisano F; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Soria F; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Čapoun O; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.; Bauerová L; Department of Pathology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.; Pešl M; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.; Bruins HM; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Runneboom W; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; Herdegen S; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Breyer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.; Brisuda A; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia.; Calatrava A; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Rubio-Briones J; Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Seles M; Department of Urology, Medical University of Graz, Graz, Austria.; Mannweiler S; Department of Pathology, Medical University of Graz, Graz, Austria.; Bosschieter J; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Kusuma VRM; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Ashabere D; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Huebner N; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Cotte J; Department of Urology, Pitié Salpétrière Hospital, AP-HP, GRC n°5, ONCOTYPE-URO, Sorbonne University, Paris, France.; Mertens LS; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Claps F; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Masson-Lecomte A; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Liedberg F; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Cohen D; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.; Lunelli L; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; Cussenot O; Department of Urology, Tenon Hospital, AP-HP, Sorbonne University, Paris, France.; El Sheikh S; Department of Pathology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.; Volanis D; Department of Urology, Royal Free Hospital, Royal Free London NHS Foundation Trust, London, UK.; Côté JF; Department of Pathology, Pitié Salpétrière Hospital, AP-HP, Pierre et Marie Curie Medical School, Sorbonne University, Paris, France.; Rouprêt M; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Pitié Salpétrière Hospital, AP-HP, GRC n°5, ONCOTYPE-URO, Sorbonne University, Paris, France.; Haitel A; Department of Pathology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Shariat SF; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Mostafid AH; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, The Stokes Centre for Urology, Royal Surrey Hospital, Guildford, UK.; Nieuwenhuijzen JA; Department of Urology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.; Zigeuner R; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Medical University of Graz, Graz, Austria.; Dominguez-Escrig JL; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Pathology, Fundación Instituto Valenciano de Oncología, Valencia, Spain.; Hacek J; Department of Pathology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia.; Zlotta AR; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Burger M; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; Evert M; Department of Pathology, University of Regensburg, Regensburg, Germany.; Hulsbergen-van de Kaa CA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Kiemeney LALM; Department of Health Evidence and Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Soukup V; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, General Teaching Hospital and 1st Faculty of Medicine, Charles University Praha, Prague, Czechia.; Molinaro L; Department of Pathology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Gontero P; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Città della Salute e della Scienza, University of Torino School of Medicine, Torino, Italy.; Llorente C; Department of Urology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.; Algaba F; Deaprtment of Pathology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; Palou J; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Fundacio Puigvert, Universitat Autònoma de Barcelona, Barcelona, Spain.; N'Dow J; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; Ribal MJ; European Association of Urology Guidelines Office, Arnhem, The Netherlands.; van der Kwast TH; Laboratory Medicine Program, University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada.; Babjuk M; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Urology, Teaching Hospital Motol and 2nd Faculty of Medicine, Charles University Praha, Prague, Czechia; Department of Urology, Comprehensive Cancer Center, Medical University Vienna, Vienna General Hospital, Vienna, Austria.; Sylvester RJ; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands.; van Rhijn BWG; Department of Surgical Oncology (Urology), Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany; European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel, Arnhem, The Netherlands; Department of Surgical Oncology (Urology), University Health Network, Princess Margaret Cancer Center, University of Toronto, Toronto, Canada. Electronic address: b.v.rhijn@nki.nl.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE